Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Boris Hugle, MD, MSc, Laura Mueller & Thierry Levade, MD, PhD  |  June 1, 2014

A case study reveals how late presentation of this rare, autosomal-recessive disorder, which can involve arthritis-like symptoms, can be mistaken for JIA

Filed under:ConditionsRheumatoid Arthritis Tagged with:Juvenile idiopathic arthritisMethotrexatepatient careRheumatoid arthritisrheumatologist

Tacrolimus Aids Joint Remodeling in Rheumatoid Arthritis

Yuichi Nishioka, MD  |  May 22, 2014

When added to a regimen of low-dose methotrexate, the calcineurin inhibitor was found to increase bone formation in a patient with erosive RA.

Filed under:ConditionsRheumatoid Arthritis Tagged with:Rheumatoid arthritistacrolimusTreatment

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2014

Information on oral anticoagulant apixaban, apremilast for active psoriatic arthritis, hyaluronic acid and methotrexate injections, and drug safety updates rheumatologists need to know

Filed under:AnalgesicsBiologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:anti-inflammatoryapremilastBiologicsdrugMethotrexateOsteoarthritispatient careradiographRheumatoid arthritisrheumatologistrheumatologySafetyTofacitinib

Recipients of Ephraim P. Engleman Endowed Resident Research Preceptorship Award in Rheumatology Meet Physician Who Helped Shape Their Careers

From the College  |  May 1, 2014

Award’s namesake, 103-year-old rheumatologist Ephraim P. Engleman, MD, met 10 winners of research funding established in his name by the Rheumatology Research Foundation in 2006

Filed under:ConditionsFrom the CollegeProfessional TopicsProfilesResearch RheumRheumatoid Arthritis Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)AwardsBiologicsdrugMethotrexateProfileRheumatoid arthritisrheumatologistRheumatology Research Foundation

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS  |  May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Filed under:ConditionsVasculitis Tagged with:drugGiant Cell ArteritisGlucocorticoidsimaginginfliximablarge-vessel vasculitisMethotrexatePainpatient careprednisonerheumatologistrituximabTakayasu’s ArteritistocilizumabTreatmentVasculitis

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD  |  May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-inflammatoryaxial skeletal inflammationaxial spondyloarthritis (SpA)DrugsepidemiologyimagingPainpatient careradiographResearchrheumatologistrituximabterminologyTofacitinib

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:BiologicsdrugDrug SafetyMethotrexateOsteoporosisRheumatoid arthritisrheumatologySafetySystemic lupus erythematosus

Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein  |  April 2, 2014

Poverty, poor access to healthcare, cultural myths present challenges for rheumatologists caring for patients with RA in developing economic regions

Filed under:ConditionsMeeting ReportsPractice SupportQuality Assurance/ImprovementRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingBiologicsdrugglobal healthHealthcareInternationalMethotrexatePractice ManagementRheumatoid arthritisrheumatologist

TNF Inhibitors & RA

Richard Quinn  |  March 24, 2014

Anti-tumor necrosis factor agents may have cardioprotective effects in rheumatoid arthritis patients

Filed under:Uncategorized Tagged with:acute coronary syndromeanti-tumor necrosis factorRheumatoid arthritisTNF

Approval Expected for Apremilast

Richard Quinn  |  March 5, 2014

New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:Ankylosing SpondylitisapremilastCelgene Corp.PsoriasisPsoriatic Arthritis

  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences